Loading MEDP company information
Open the financials tab to load SEC data
Loading MEDP data
Loading MEDP data
Loading MEDP data
Loading MEDP data
Loading MEDP data
Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
MEDP's RSI(14) currently reads 68. RSI compares the size of recent up moves to down moves to flag stretched conditions in either direction. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. As with any single metric, weigh this alongside MEDP's full indicator set. → Learn more
ADX currently reads 32. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now MEDP shows +DI sits above -DI, favoring the upside, putting it in the 'strong trend' range on ADX. As with any single metric, weigh this alongside MEDP's full indicator set. → Learn more
MEDP's Bollinger Band width is at the 52th percentile (mid-range) of its past year, and the squeeze indicator is not currently active. A Bollinger Band squeeze means price volatility has contracted well below its usual range. A squeeze is often followed by a volatility expansion in either direction. Treat this as one data point on MEDP, not a standalone signal. → Learn more
MEDP's OBV is currently rising (1.1x), and the up/down volume ratio is 1.1x. OBV (On-Balance Volume) uses the cumulative direction of volume to estimate accumulation or distribution. As with any single metric, weigh this alongside MEDP's full indicator set. → Learn more
MEDP's recent volume is running at 0.9x its usual level. It's a simple multiple of current volume over the trailing average — a proxy for how much attention the stock is getting — a reference point for whether order flow is concentrating around this stock. Cross-check this against MEDP's other indicators above before drawing a conclusion. → Learn more
MEDP's change over the last 5 trading days is +8.2%, and over the last 1 trading day is +2.3%. These reflect only what has already happened over the past day and week, not what happens next.
MEDP's current price is 2.2% below its 20-day high. Distance from the recent high is a reference point for how close price is to potential resistance. On this measure it currently falls in the 'near resistance' category. This reading is specific to MEDP on this scan date and can change quickly. → Learn more
MEDP's ATR% currently reads 3.3%, a 'daily range' level. ATR% expresses how large the average daily move has been recently, as a percentage of price. This reading is specific to MEDP on this scan date and can change quickly. → Learn more
MEDP's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +9.6%. MEDP gained more (or lost less) than SPY over this stretch. This reading is specific to MEDP on this scan date and can change quickly. → Learn more
Stocks holding OBV Accumulation reached +15% 24.7% of the time, versus a 24.7% base rate — not a statistically significant difference (9096 cases). Treat this as one data point on MEDP, not a standalone signal. → OBV Accumulation
Measured (n=11420), the hit-rate for ADX Trend Strengthening (24.5%) was not statistically distinguishable from the base rate (24.7%). This reading is specific to MEDP on this scan date and can change quickly. → ADX Trend Strengthening
Measured (n=12815), the hit-rate for +DI Dominance (24.6%) was not statistically distinguishable from the base rate (24.7%). Treat this as one data point on MEDP, not a standalone signal. → +DI Dominance
Stocks holding Weekly Squeeze reached +15% 22.3% of the time, versus a 24.7% base rate — not a statistically significant difference (8568 cases). As with any single metric, weigh this alongside MEDP's full indicator set. → Weekly Squeeze
Stocks holding Relative Strength +8pp (20D) reached +15% 31.7% of the time, versus a 24.7% base rate — not a statistically significant difference (5325 cases). Cross-check this against MEDP's other indicators above before drawing a conclusion. → Relative Strength +8pp (20D)
No significant edge was measured for Stage 2 Trend Template: 14.8% versus a 24.7% base rate across 3790 cases. As with any single metric, weigh this alongside MEDP's full indicator set. → Stage 2 Trend Template
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (MEDP diagnostic as of 2026.10.24 16:46).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.